December 16, 2017 5:10 AM ET

Pharmaceuticals

Company Overview of Adare Pharmaceuticals, Inc.

Company Overview

Adare Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for customers worldwide. It develops Lactéol, a proprietary combination of Lactobacillus fermentum and Lactobacillus delbrueckii, and fermented culture medium (neutralized), which is used in addition to rehydration and dietary measures, as a symptomatic supplemental treatment for diarrhea in adults and children. The company also develops products for various therapeutic categories, such as cardiovascular, pain management, GI, and CNS; taste masking and orally disintegrating tablets, drug release products, and bioavailability enhancement products; and Rx and orally disintegrating tablets. It offers its pro...

Princeton Pike Corporate Center

1200 Lenox Drive

Suite 100

Lawrenceville, NJ 08648

United States

Phone:

908-429-4479

Fax:

908-927-9648

Key Executives for Adare Pharmaceuticals, Inc.

Chief Executive Officer and President
Age: 51
Chief Financial Officer and Vice President of Finance
Chief Medical Officer and Vice President of Research & Development
Age: 57
Vice President of Human Resources
Vice President of Commercial & Strategic Development
Compensation as of Fiscal Year 2017.

Adare Pharmaceuticals, Inc. Key Developments

Adare Pharmaceuticals, Inc. Presents at BIO International Conference 2017, Jun-21-2017 01:30 PM

Adare Pharmaceuticals, Inc. Presents at BIO International Conference 2017, Jun-21-2017 01:30 PM. Venue: San Diego Convention Center, San Diego, California, United States.

Adare Pharmaceuticals, Inc. Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017

Adare Pharmaceuticals, Inc. Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017 . Venue: Hilton San Francisco Union Square, 333 O'Farrell Street, San Francisco, California, United States.

Adare Pharmaceuticals Appoints Dr. Peter Richardson as Vice President, Research & Development and Chief Medical Officer

Adare Pharmaceuticals, Inc. announced that Dr. Peter Richardson has joined the company as Vice President, Research & Development and Chief Medical Officer. Dr. Richardson will be responsible for leading the Research and Development efforts worldwide and for the successful development of the company’s pipeline. Dr. Richardson brings 30 years of medical practice, research and development experience in the pharmaceutical and medical device industry. He joins the team from Novartis Corporation where he was most recently the Chief Medical Officer for its eye care division Alcon. In this role he held multiple responsibilities including leading the company's clinical, regulatory and safety organizations globally and serving as its ad-interim head of research and development for its Pharmaceutical business.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
January 4, 2017
Viactiv Holdings, LLC
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Adare Pharmaceuticals, Inc., please visit www.adarepharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.